Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study
Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardizat...
Saved in:
Published in | Clinical chemistry and laboratory medicine Vol. 48; no. 11; pp. 1593 - 1601 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article Conference Proceeding |
Language | English |
Published |
Berlin
Walter de Gruyter
01.11.2010
De Gruyter |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population. Methods: AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18–85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire. Results: AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11–34 U/L (0.18–0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8–41 U/L (0.13–0.68 μkat/L) for females and 9–59 U/L (0.15–0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6–40 U/L (0.11–0.66 μkat/L) for females and 12–68 U/L (0.20– 1.13 μkat/L) for males, respectively. Conclusions: For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Clin Chem Lab Med 2010;48:1593–601. |
---|---|
AbstractList | Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population.
AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18-85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire.
AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11-34 U/L (0.18-0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8-41 U/L (0.13-0.68 μkat/L) for females and 9-59 U/L (0.15-0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6-40 U/L (0.11-0.66 μkat/L) for females and 12-68 U/L (0.20- 1.13 μkat/L) for males, respectively.
For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population. Methods: AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18–85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire. Results: AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11–34 U/L (0.18–0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8–41 U/L (0.13–0.68 μkat/L) for females and 9–59 U/L (0.15–0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6–40 U/L (0.11–0.66 μkat/L) for females and 12–68 U/L (0.20– 1.13 μkat/L) for males, respectively. Conclusions: For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Clin Chem Lab Med 2010;48:1593–601. Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population.BACKGROUNDAspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population.AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18-85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire.METHODSAST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18-85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire.AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11-34 U/L (0.18-0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8-41 U/L (0.13-0.68 μkat/L) for females and 9-59 U/L (0.15-0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6-40 U/L (0.11-0.66 μkat/L) for females and 12-68 U/L (0.20- 1.13 μkat/L) for males, respectively.RESULTSAST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11-34 U/L (0.18-0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8-41 U/L (0.13-0.68 μkat/L) for females and 9-59 U/L (0.15-0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6-40 U/L (0.11-0.66 μkat/L) for females and 12-68 U/L (0.20- 1.13 μkat/L) for males, respectively.For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations.CONCLUSIONSFor AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver damage. The aim of this study was to define the reference intervals (RIs) for these enzymes in adults, paying attention to standardization of the methods used and careful selection of the reference population. Methods: AST, ALT and GGT were measured with commercial analytical systems standardized to the IFCC-recommended reference measurement systems. Three centers (two in Italy and one in China) measured their own freshly collected samples; one of these centers also measured frozen samples from the Nordic Countries RI Project and from a Turkish center. RIs were generated using non-parametric techniques from the results of 765 individuals (411 females and 354 males, 18–85 years old) selected on the basis of the results of other laboratory tests and a specific questionnaire. Results: AST results from the four regions (Milan, Beijing, Bursa and Nordic Countries) were statistically different, but these differences were too small to be clinically relevant. Likewise, differences between the upper reference limits for genders was only 1.7 U/L (0.03 μkat/L), allowing a single RI of 11–34 U/L (0.18–0.57 μkat/L) to be defined. Interregional differences were not statistically significant for ALT, but partitioning was required due to significant gender differences. RIs for ALT were 8–41 U/L (0.13–0.68 μkat/L) for females and 9–59 U/L (0.15–0.99 μkat/L) for males, respectively. The upper reference limits for GGT from the Nordic Country population were higher than those from the other three regions and results from this group were excluded from final calculations. The GGT RIs were 6–40 U/L (0.11–0.66 μkat/L) for females and 12–68 U/L (0.20– 1.13 μkat/L) for males, respectively. Conclusions: For AST and ALT, the implementation of common RIs appears to be possible, because no differences between regions were observed. However, a common RI for GGT that is applicable worldwide appears unlikely due to differences among populations. Clin Chem Lab Med 2010;48:1593–601. |
Author | Henny, Joseph Ceriotti, Ferruccio Özarda, Yeşim Queraltó, Josep Ziyu, Shen Panteghini, Mauro Boyd, James C. Chen, Baorong |
Author_xml | – sequence: 1 givenname: Ferruccio surname: Ceriotti fullname: Ceriotti, Ferruccio organization: Diagnostica e Ricerca S. Raffaele, Istituto Scientifico Universitario S. Raffaele, Milano, Italy – sequence: 2 givenname: Joseph surname: Henny fullname: Henny, Joseph organization: Laboratoire de Biologie Clinique, Centre de Médicine Préventive, Vandoeuvre-lès-Nancy, France – sequence: 3 givenname: Josep surname: Queraltó fullname: Queraltó, Josep organization: Servei de Bioquímica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain – sequence: 4 givenname: Shen surname: Ziyu fullname: Ziyu, Shen organization: National Center for Clinical Laboratory, Beijing Hospital Compound, Beijing, P.R. China – sequence: 5 givenname: Yeşim surname: Özarda fullname: Özarda, Yeşim organization: Uludag University Medical School, Department of Biochemistry and Clinical Biochemistry, Bursa, Turkey – sequence: 6 givenname: Baorong surname: Chen fullname: Chen, Baorong organization: Beijing Aerospace General Hospital, Beijing, P.R. China – sequence: 7 givenname: James C. surname: Boyd fullname: Boyd, James C. organization: University of Virginia Health System, Department of Pathology, Charlottesville, VA, USA – sequence: 8 givenname: Mauro surname: Panteghini fullname: Panteghini, Mauro organization: Centro Interdipartimentale per la Riferibilità Metrologica in Medicina di Laboratorio (CIRME), Università degli Studi, Milano, Italy |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23441969$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21034260$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkctu1DAUhi3Uil5gyRZ5g6ASKXZ8y7CrAh0qTUURw9pyMifIENtT20HMa8F78Ex42ikIhMTKl_Od2_8foT0fPCD0iJJTKqh40baLy9OalCej4h46pJypijNG927uvJKypgfoKKVPhFAhuLqPDmpKGK8lOUTf2uBc8DjCABF8D9j6DPGLGRMeQsQmrU3MJgM2zvqQo_GpkCYBfnb2fnnyHJvReOv_GV8sT7DxK_zje_VxnLJxmxH_QcznhbAeJ4iTe1mGSNOYS-MYXEnEF-dti135sj1sp8IpT6vNA7Q_lPHg4e48Rh_OXy_bN9Xi7fyiPVtUPZMkl71B0KEnHZFGUNrRogNINYCpO1UDH_hMCTMQoKLZRqVUpoGuG5pGkBkYdoye3tZdx3A9Qcra2dTDWPaFMCWtJOOK0kYU8vGOnDoHK72O1pm40XcyF-DJDjCpN-NQNOht-s0xzulMzgrHbrk-hpSKJ7q3RXwbfJHNjpoSvTVdb03XW9N1Mb1kVX9l3RX-D29Thq-_YBM_a6mYEvrdkusrTq8uad3oV-wn_sS96Q |
CitedBy_id | crossref_primary_10_1016_j_abb_2019_108062 crossref_primary_10_1515_tjb_2015_0030 crossref_primary_10_1038_ajg_2016_517 crossref_primary_10_1016_j_eclinm_2022_101435 crossref_primary_10_1515_cclm_2012_0682 crossref_primary_10_1515_cclm_2013_0371 crossref_primary_10_1515_cclm_2019_0055 crossref_primary_10_1016_j_cca_2014_01_025 crossref_primary_10_1016_j_clinbiochem_2017_03_024 crossref_primary_10_1111_liv_15164 crossref_primary_10_2217_fmb_2017_0131 crossref_primary_10_1016_S1701_2163_16_35105_2 crossref_primary_10_1177_147323001204000225 crossref_primary_10_3390_livers1040023 crossref_primary_10_1007_s11356_022_25072_4 crossref_primary_10_1007_s11357_023_00895_2 crossref_primary_10_1515_cclm_2018_1341 crossref_primary_10_1186_s41687_023_00589_5 crossref_primary_10_11613_BM_2017_038 crossref_primary_10_1515_labmed_2016_0040 crossref_primary_10_1016_j_cca_2013_03_030 crossref_primary_10_1080_10408363_2018_1476455 crossref_primary_10_5662_wjm_v6_i1_93 crossref_primary_10_3390_metabo13070850 crossref_primary_10_1371_journal_pone_0260022 crossref_primary_10_1016_j_cca_2021_08_012 crossref_primary_10_1515_cclm_2020_0015 crossref_primary_10_3390_jcm12093174 crossref_primary_10_1002_jcph_913 crossref_primary_10_1515_labmed_2020_0131 crossref_primary_10_3390_jpm13091319 crossref_primary_10_1002_hep4_1794 crossref_primary_10_1373_clinchem_2017_274977 crossref_primary_10_1055_s_0042_1749117 crossref_primary_10_3389_fmed_2024_1431578 crossref_primary_10_34172_mejdd_2020_182 crossref_primary_10_5114_aoms_199704 crossref_primary_10_1515_cclm_2016_0035 crossref_primary_10_1111_dth_15052 crossref_primary_10_1016_j_cca_2016_09_015 crossref_primary_10_3390_nu14132688 crossref_primary_10_1016_S0992_5945_20_30234_8 crossref_primary_10_7759_cureus_32541 crossref_primary_10_1111_j_1478_3231_2011_02749_x crossref_primary_10_1373_clinchem_2015_240515 crossref_primary_10_1016_j_mayocp_2020_07_024 crossref_primary_10_1016_j_cca_2016_10_004 crossref_primary_10_1155_2013_429037 crossref_primary_10_1016_j_cca_2021_12_026 crossref_primary_10_2478_jomb_2019_0046 crossref_primary_10_1016_j_imu_2023_101369 crossref_primary_10_1016_j_jep_2025_119371 crossref_primary_10_1093_ajcp_aqw069 crossref_primary_10_3168_jds_2015_10265 crossref_primary_10_1371_journal_pone_0072916 crossref_primary_10_1111_ijpo_12152 crossref_primary_10_1097_QAD_0000000000001278 crossref_primary_10_3389_fmed_2023_1094733 crossref_primary_10_1016_j_fsi_2022_07_034 crossref_primary_10_1097_MEG_0000000000002325 crossref_primary_10_1177_2168479017700679 crossref_primary_10_1515_cclm_2018_0152 crossref_primary_10_1002_jpn3_12460 crossref_primary_10_1111_1751_2980_12475 crossref_primary_10_1515_CCLM_2011_741 crossref_primary_10_3109_10826084_2011_620053 crossref_primary_10_1515_cclm_2016_0661 crossref_primary_10_1093_toxsci_kfae143 crossref_primary_10_1111_dme_12972 crossref_primary_10_1111_liv_15068 crossref_primary_10_1002_hed_27701 crossref_primary_10_1515_labmed_2023_0042 crossref_primary_10_1002_hep_24725 crossref_primary_10_1017_S2040174416000635 crossref_primary_10_1097_MEG_0000000000001225 crossref_primary_10_1007_s12291_024_01286_w crossref_primary_10_1515_tjb_2017_0299 crossref_primary_10_1093_clinchem_hvac142 crossref_primary_10_1371_journal_pone_0302859 crossref_primary_10_1093_ajcp_aqy015 crossref_primary_10_1007_s00204_016_1723_x |
Cites_doi | 10.1515/CCLM.2010.075 10.1016/j.cca.2008.06.005 10.1016/j.cca.2005.12.033 10.1002/hep.23358 10.1016/j.cca.2009.06.021 10.1515/CCLM.2010.084 10.1111/j.1572-0241.2006.00627_6.x 10.1515/CCLM.2007.290 10.1515/CCLM.2004.121 10.1515/CCLM.2005.095 10.1309/W8J8-5AG4-WDG6-JGJ9 10.1373/clinchem.2007.098228 10.1002/hep.23200 10.1093/clinchem/48.11.1987 10.7326/0003-4819-137-1-200207020-00006 10.1080/00365510410006694 10.1046/j.1423-0410.2003.00347.x 10.3109/00365519509089619 10.1046/j.1440-1746.2002.02881.x 10.1016/S0009-8981(02)00341-8 10.1136/jcp.2007.053637 10.1016/j.ab.2007.10.025 10.1373/clinchem.2007.091843 10.1080/00365510410002742 10.1001/archinternmed.2007.131 10.1258/acb.2008.008170 10.1515/CCLM.2004.133 10.1023/A:1022809430756 10.1373/clinchem.2003.027953 |
ContentType | Journal Article Conference Proceeding |
Copyright | 2015 INIST-CNRS |
Copyright_xml | – notice: 2015 INIST-CNRS |
CorporateAuthor | Committee on Reference Systems for Enzymes (C-RSE) IFCC Committee on Reference Intervals and Decision Limits (C-RIDL) |
CorporateAuthor_xml | – name: Committee on Reference Systems for Enzymes (C-RSE) – name: IFCC Committee on Reference Intervals and Decision Limits (C-RIDL) |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1515/CCLM.2010.315 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1437-4331 |
EndPage | 1601 |
ExternalDocumentID | 21034260 23441969 10_1515_CCLM_2010_315 ark_67375_QT4_P41PM128_D |
Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GroupedDBID | --- -~0 0R~ 0~D 1CY 29B 354 36B 4.4 53G 5GY 5RE 9-L AAAEU AABBZ AAFNC AAFPC AAGVJ AAILP AALGR AAONY AAOQK AAOTM AAOWA AAPJK AAQCX AASQH AAWFC AAXCG ABAOT ABAQN ABFKT ABFQV ABIQR ABJNI ABLJU ABMIY ABPLS ABRDF ABRQL ABUBZ ABUVI ABVMU ABWLS ABXMZ ABYBW ACEFL ACGFS ACIWK ACMKP ACPMA ACPRK ACXLN ACZBO ADALX ADDWE ADEQT ADGQD ADGYE ADOZN ADUQZ AEDGQ AEGVQ AEICA AEJTT AEKEB AENEX AEQDQ AERZL AEXIE AFAUI AFBAA AFBQV AFCXV AFGDO AFGNR AFQUK AFRAH AFYRI AGBEV AGGNV AHOVO AHVWV AHXUK AIERV AIKXB AJATJ AJHHK AKXKS ALMA_UNASSIGNED_HOLDINGS ALUKF ALYBR AMAVY ASPBG ASYPN AVWKF AZFZN AZMOX BAKPI BBCWN BCIFA BSCLL BWHEM CAG CGQUA COF CS3 DA2 DBYYV DU5 EJD EMOBN F5P FSTRU HZ~ IL9 IY9 KDIRW N9A O9- OBC OBS OEB OES OHH OVD P2P PQQKQ QD8 RDG SA. SLJYH TEORI UK5 WTRAM ~Z8 AARRE AAYXX ABDRH ACDEB ACRPL ACUND ACYCL ADNMO AECWL AFBDD AFSHE AGQPQ AIWOI CITATION EBS LVMAB .55 .GJ AI. IQODW VH1 X7M CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c360t-66e51fc0b06a511b1621e67fea2b72e4f4975af0e1581b16667a8ebbf88509ea3 |
ISSN | 1434-6621 1437-4331 |
IngestDate | Thu Jul 10 18:56:09 EDT 2025 Thu Apr 03 07:08:52 EDT 2025 Mon Jul 21 09:15:47 EDT 2025 Thu Apr 24 22:53:42 EDT 2025 Tue Jul 01 02:49:12 EDT 2025 Wed Oct 30 09:48:35 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Reference value Enzyme Transferases Multicenter study alanine aminotransferase Result aspartate aminotransferase Medicine Transaminases Aspartate transaminase Clinical biology Alanine transaminase γ-glutamyl transferase Serum reference intervals |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c360t-66e51fc0b06a511b1621e67fea2b72e4f4975af0e1581b16667a8ebbf88509ea3 |
Notes | cclm.2010.315.pdf ark:/67375/QT4-P41PM128-D istex:F5BEE552B8AE7DDFC46082E4A20CDF7AE7E4D083 ArticleID:cclm.2010.315 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21034260 |
PQID | 763471185 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_763471185 pubmed_primary_21034260 pascalfrancis_primary_23441969 crossref_citationtrail_10_1515_CCLM_2010_315 crossref_primary_10_1515_CCLM_2010_315 istex_primary_ark_67375_QT4_P41PM128_D |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-11-01 |
PublicationDateYYYYMMDD | 2010-11-01 |
PublicationDate_xml | – month: 11 year: 2010 text: 2010-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin |
PublicationPlace_xml | – name: Berlin – name: Germany |
PublicationTitle | Clinical chemistry and laboratory medicine |
PublicationTitleAlternate | Clin Chem Lab Med |
PublicationYear | 2010 |
Publisher | Walter de Gruyter De Gruyter |
Publisher_xml | – name: Walter de Gruyter – name: De Gruyter |
References | p_27 Roberts WL (p_18) 2006 p_28 p_29 p_23 p_24 p_25 p_26 p_20 p_22 p_16 p_38 p_17 p_39 p_34 p_13 Prati D (p_30) 2002; 137 p_35 p_6 p_14 p_36 p_37 p_7 p_9 Ceriotti F (p_8) 2007; 28 Lahti A (p_19) 2002; 48 p_31 p_10 p_32 p_11 p_33 Ceriotti F (p_21) 2007; 31 |
References_xml | – ident: p_6 doi: 10.1515/CCLM.2010.075 – volume: 28 start-page: 115 year: 2007 ident: p_8 publication-title: Clin Biochem Rev – ident: p_38 doi: 10.1016/j.cca.2008.06.005 – ident: p_13 doi: 10.1016/j.cca.2005.12.033 – ident: p_24 doi: 10.1002/hep.23358 – ident: p_36 doi: 10.1016/j.cca.2009.06.021 – ident: p_26 doi: 10.1515/CCLM.2010.084 – ident: p_35 doi: 10.1111/j.1572-0241.2006.00627_6.x – ident: p_39 doi: 10.1515/CCLM.2007.290 – ident: p_16 doi: 10.1515/CCLM.2004.121 – ident: p_23 doi: 10.1515/CCLM.2005.095 – ident: p_34 doi: 10.1309/W8J8-5AG4-WDG6-JGJ9 – ident: p_11 doi: 10.1373/clinchem.2007.098228 – start-page: 2251 year: 2006 ident: p_18 publication-title: Philadelphia, PA: Elsevier Saunders – ident: p_25 doi: 10.1002/hep.23200 – volume: 48 start-page: 338 year: 2002 ident: p_19 publication-title: Clin Chem doi: 10.1093/clinchem/48.11.1987 – volume: 137 start-page: 1 year: 2002 ident: p_30 publication-title: Ann Intern Med doi: 10.7326/0003-4819-137-1-200207020-00006 – ident: p_14 doi: 10.1080/00365510410006694 – ident: p_33 doi: 10.1046/j.1423-0410.2003.00347.x – ident: p_17 doi: 10.3109/00365519509089619 – ident: p_27 doi: 10.1046/j.1440-1746.2002.02881.x – ident: p_29 doi: 10.1016/S0009-8981(02)00341-8 – volume: 31 start-page: 254 year: 2007 ident: p_21 publication-title: Biochim Clin – ident: p_32 doi: 10.1136/jcp.2007.053637 – ident: p_37 doi: 10.1016/j.ab.2007.10.025 – ident: p_10 doi: 10.1373/clinchem.2007.091843 – ident: p_31 doi: 10.1080/00365510410002742 – ident: p_22 doi: 10.1001/archinternmed.2007.131 – ident: p_7 doi: 10.1258/acb.2008.008170 – ident: p_9 doi: 10.1515/CCLM.2004.133 – ident: p_28 doi: 10.1023/A:1022809430756 – ident: p_20 doi: 10.1373/clinchem.2003.027953 |
SSID | ssj0015547 |
Score | 2.2975829 |
Snippet | Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of... Background: Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of... Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) measurements are important for the assessment of liver... |
SourceID | proquest pubmed pascalfrancis crossref istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1593 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over alanine aminotransferase Alanine Transaminase - blood aspartate aminotransferase Aspartate Aminotransferases - blood Biological and medical sciences Blood Chemical Analysis - standards Ethnic Groups Female gamma-Glutamyltransferase - blood General aspects Humans International Agencies Investigative techniques, diagnostic techniques (general aspects) Laboratories - standards Male Medical sciences Middle Aged reference intervals Reference Values Reproducibility of Results Sex Factors Young Adult γ-glutamyl transferase |
Title | Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study |
URI | https://api.istex.fr/ark:/67375/QT4-P41PM128-D/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/21034260 https://www.proquest.com/docview/763471185 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXGKgFvMAaUj8kPFDF1gaRx4pS3Les-0LoNkaKNl8hJHWmiS1GaIsbPgv_B7-GRe53ES7ZOCF6iqrlOotwT-9j33GtCXnBummOe9A3pedJgY5YYEWNjgyeAoAgI0tjBBOfhobs3Yu9OnJOlpd811dI8j17H3xfmlfyPV-E_8Ctmyf6DZ_VF4Q_4Df6FI3gYjtd9vHCo8avExrjauE1FA0rXYvy8GTwvW03xGbt6ixFVNCL7ipWUlagSehkM0cuuOD9Lp7nitjKD8Q756OaHoNPrK9XnRKRIUhdaHaCVepiOP-hs2SiOz8X5BWrbG5a7u8ryLO3CO5uruEEmZ_NJPityX6AD2t_x_UL6iFpSrD-ti-Ji-ATmokdBsK94uMwArHEhLlNwHRwentZCHdU67wgFe8GRPqNXmqBB99P-6ai-HILSksZyyDZ8W9n8opI2F506s5nhukUmdtXrM6-ObqvWhwPBs2t8wHKLy18baxxVlsP3D4aFQtAu8lKbNb2vjLVaAdmzgYf23f4t0urZ3HOWSWtzd2vwUUfAgOapjYGqZy_rw8JN3zRu2eBTLewavqG-V8wAe0mxN8vNkydFooJ7ZPUyvZQeazTfJ0syXSF3_ArBK-T2sATtA_KjwCrVWKUaqxSwSjVW6VUU0leA1PUNWqJ00fmDYJ0CQumvnxqdtGEB2FyHG1KFzLe0xCVFXEJDirikNVxShctVMtoZBP6eUe4zYsS2a-bweqVjJbEZma6A-UdkweuWLk-k6EW8J1nC-twRiSktx8OzrsuFJ6Mo8Tyg21LYD8lyOk3lY0JNS9o9ycU4ZpIBjxAsNhkXggsntmOWtMlG5a0wLovw414wkxAn4-DcEJ0bonNDcG6bvNTmX4rqMzcaKtdrK5F9Rskmd8L3AQuPmXU8BCYabrfJWgMbukEFyDahFVhC8DqGD0Uqp_NZCEwEmCzw-zZ5VIDosrGFlURd88nfrv6U3L38aJ-R5Tyby-fA6vNorfwA_gBhEvqS |
linkProvider | Walter de Gruyter |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Clinical+chemistry+and+laboratory+medicine&rft.atitle=Common+reference+intervals+for+aspartate+aminotransferase+%28AST%29%2C+alanine+aminotransferase+%28ALT%29+and+%CE%B3-glutamyl+transferase+%28GGT%29+in+serum%3A+results+from+an+IFCC+multicenter+study&rft.au=CERIOTTI%2C+Ferruccio&rft.au=HENNY%2C+Joseph&rft.au=QUERALTO%2C+Josep&rft.au=SHEN+ZIYU&rft.date=2010-11-01&rft.pub=De+Gruyter&rft.issn=1434-6621&rft.volume=48&rft.issue=11&rft.spage=1593&rft.epage=1601&rft_id=info:doi/10.1515%2FCCLM.2010.315&rft.externalDBID=n%2Fa&rft.externalDocID=23441969 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon |